Structural Characterization of the Low-Molecular-Weight Heparin Dalteparin by Combining Different Analytical Strategies

A number of low molecular weight heparin (LMWH) products are available for clinical use and although all share a similar mechanism of action, they are classified as distinct drugs because of the different depolymerisation processes of the native heparin resulting in substantial pharmacokinetic and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisio, Antonella, Urso, Elena, Guerrini, Marco, de Wit, Pauline, Torri, Giangiacomo, Naggi, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152074/
https://www.ncbi.nlm.nih.gov/pubmed/28672818
http://dx.doi.org/10.3390/molecules22071051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152074/
https://www.ncbi.nlm.nih.gov/pubmed/28672818
http://dx.doi.org/10.3390/molecules22071051

Ejemplares similares